National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting, 9477-9478 [2016-03930]
Download as PDF
<![CDATA[
9477
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
eliminate existing barriers to treatment
so that young women have access to
high quality breast cancer treatment and
care. Results will also be used to
improve care and services provided to
young women diagnosed with breast
cancer. Study findings will be
disseminated through reports,
presentations, and publications.
OMB approval is requested for one
year. Participation is voluntary and
there are no costs to respondents other
than their time. The total estimated
annualized burden hours are 1,241.
ESTIMATED TOTAL BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Sample 1—Breast cancer survivors recruited
from state cancer registries.
Sample 2—Breast cancer survivors associated with advocacy groups (ineligibles).
Sample 2—Breast cancer survivors associated with advocacy groups (eligible and
complete).
Breast Cancer in Young Women Survey
(Mail-in or web-based questionnaire).
Breast Cancer in Young Women Survey
(Screener only).
Breast Cancer in Young Women Survey
(Screener and Web-based questionnaire).
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–04013 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
EDT, March 31, 2016; 9:00 a.m.–12:00 p.m.,
EDT, April 1, 2016.
Place: Centers for Disease Control and
Prevention, Global Communications Center,
Building 19, Auditorium B, 1600 Clifton
Road NE., Atlanta, Georgia, 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary,
Health and Human Services regarding (1) the
practice of healthcare infection prevention
and control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
VerDate Sep<11>2014
18:07 Feb 24, 2016
Jkt 238001
Matters for Discussion: The agenda will
include updates on CDC’s activities for
prevention of healthcare associated
infections (HAIs), updates on antimicrobial
stewardship, an update on Draft Guideline
for Prevention of Infections in Healthcare
Personnel, chlorhexidine gluconateimpregnated dressings, and an update from
the workgroup for considerations on
endoscope reprocessing.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, 1600
Clifton Road NE., Mailstop A–07, Atlanta,
Georgia 30333. Telephone (404) 639–4045.
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–03929 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff,
Announces the Following Meeting
Name: ICD–10 Coordination and
Maintenance (C&M) Committee meeting.
Time and Date: 9:00 a.m.–5:00 p.m.,
EST, March 9–10, 2016.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
1,200
1
22/60
25
1
2/60
2,000
1
24/60
7500 Security Boulevard, Baltimore,
Maryland 21244.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 240
people. We will be broadcasting the
meeting live via Webcast at https://
www.cms.gov/live/.
Security Considerations: Due to in
creased security requirements CMS has
instituted stringent procedures for
entrance into the building by nongovernment employees. Attendees will
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building.
Attendees who wish to attend the
March 9–10, 2016 ICD–10–CM C&M
meeting must submit their name and
organization by March 1, 2016 for
inclusion on the visitor list. This visitor
list will be maintained at the front desk
of the CMS building and used by the
guards to admit visitors to the meeting.
Participants who attended previous
Coordination and Maintenance meetings
will no longer be automatically added to
the visitor list. You must request
inclusion of your name prior to each
meeting you wish attend.
Please register to attend the meeting
on-line at: https://www.cms.hhs.gov/
apps/events/. Please contact Mady Hue
(410–786–4510 or Marilu.hue@
cms.hhs.gov), for questions about the
registration process.
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
and ICD–10 Procedure Coding System.
Matters for Discussion: Agenda items
include: March 9–10, 2016.
E:\FR\FM\25FEN1.SGM
25FEN1
9478
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
ICD–10–PCS Topics
Removal of Thrombus and Emboli
Insertion of Endobronchial Coils
Hematopoietic Cell Transplant Donor
Fluorescence Vascular Angiography
(FVA) (FVA)
Rapid Deployment Aortic Valve
Replacement Replacement
Branch Endograft Repair of Common
Iliac Aneurysm
Total Anomalous Pulmonary Venous
Return
Administration of Andexanet Alfa
Injection for I.V. Infusion
Administration of VISTOGARD (uridine
triacetate)
Mechanical Embolectomy with Stent
Retriever Retrieve
Intracranial Aneurysm Procedure Using
Flow Diverter Stent
Spinal Bracing and Distraction System
Interbody Spinal Fusion with NanoTextured Surface
Therapeutic Artificial Rupture of
Membranes
Application of Biologic Wound Matrix
(MircoDERM)
Oxidized Zirconium on Polyethylene
Bearing Surfaces
GEM Structure and Update Requests
Addenda and Key Updates
ICD–10–CM Diagnosis Topics
mstockstill on DSK4VPTVN1PROD with NOTICES
Antenatal Screening
Clostridium difficile
Congential Sacral Dimple
Exercise Counseling
Hepatic Encephalopathy
Lacunar Infarction
Pediatric Cryptorchidism
Post-operative Seroma
Soft Tissue Sarcoma
Spinal Stenosis
Temporomandibular Joint Disorders
Zika Virus Infection
ICD–10–CM Addendum
Agenda items are subject to change as
priorities dictate.
Note: CMS and NCHS no longer provide
paper copies of handouts for the meeting.
Electronic copies of all meeting materials
will be posted on the CMS and NCHS Web
sites prior to the meeting at https://
www.cms.hhs.gov/ICD9Provider
DiagnosticCodes/03_
meetings.asp#TopOfPage and https://
www.cdc.gov/nchs/icd/icd9cm_
maintenance.htm
Contact Persons for Additional
Information: Donna Pickett, Medical Systems
Administrator, Classifications and Public
Health Data Standards Staff, NCHS, 3311
Toledo Road, Hyattsville, Maryland 20782,
email dfp4@cdc.gov, telephone 301–458–
4434 (diagnosis); Mady Hue, Health
Insurance Specialist, Division of Acute Care,
CMS, 7500 Security Boulevard, Baltimore,
Maryland 21244, email marilu.hue@
cms.hhs.gov, telephone 410–786–4510
(procedures).
VerDate Sep<11>2014
18:07 Feb 24, 2016
Jkt 238001
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–03930 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
Eastern Time, March 23, 2015; 8:15
a.m.–12:30 p.m., Eastern Time, March
24, 2015.
Public Comment Time and Date: 5:00
p.m.–6:00 p.m.*, Eastern Time, March
23, 2015.
* Please note that the public comment
period may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend the public
comment session at the start time listed.
Place: Hilton Tampa Airport
Westshore, 2225 N. Lois Avenue,
Tampa, Florida 33607; Phone: (800)
445–8667; Fax: (813) 872–0603. Audio
Conference Call via FTS Conferencing.
The USA toll-free, dial-in number is
1–866–659–0537 with a pass code of
9933701. Live Meeting CONNECTION:
https://www.livemeeting.com/cc/cdc/
join?id=GHFDT9&role=attend&pw=
ABRWH; Meeting ID: GHFDT9; Entry
Code: ABRWH.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2017.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the Advisory Board meeting includes:
NIOSH Program Update; Department of
Labor Program Update; Department of
Energy Program Update; Report by the
Dose Reconstruction Review Methods
Work Group; Dose Reconstruction
Report to the Secretary; SEC Petitions
Update; Site Profile review for: Pinellas
Plant (Clearwater, Florida); SEC
petitions for: Lawrence Livermore
National Laboratory (1974–1995;
Livermore, California), Idaho National
Laboratory (1949–1970; Scoville, Idaho),
and Argonne National Laboratory West
(1951–1979; Scoville, Idaho); and Board
Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)]
[Notices]
[Pages 9477-9478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03930]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff, Announces the Following Meeting
Name: ICD-10 Coordination and Maintenance (C&M) Committee meeting.
Time and Date: 9:00 a.m.-5:00 p.m., EST, March 9-10, 2016.
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore, Maryland 21244.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 240 people. We will be
broadcasting the meeting live via Webcast at https://www.cms.gov/live/.
Security Considerations: Due to in creased security requirements
CMS has instituted stringent procedures for entrance into the building
by non-government employees. Attendees will need to present valid
government-issued picture identification, and sign-in at the security
desk upon entering the building.
Attendees who wish to attend the March 9-10, 2016 ICD-10-CM C&M
meeting must submit their name and organization by March 1, 2016 for
inclusion on the visitor list. This visitor list will be maintained at
the front desk of the CMS building and used by the guards to admit
visitors to the meeting.
Participants who attended previous Coordination and Maintenance
meetings will no longer be automatically added to the visitor list. You
must request inclusion of your name prior to each meeting you wish
attend.
Please register to attend the meeting on-line at: https://www.cms.hhs.gov/apps/events/. Please contact Mady Hue (410-786-4510 or
Marilu.hue@cms.hhs.gov), for questions about the registration process.
Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is
a public forum for the presentation of proposed modifications to the
International Classification of Diseases, Tenth Revision, Clinical
Modification and ICD-10 Procedure Coding System.
Matters for Discussion: Agenda items include: March 9-10, 2016.
[[Page 9478]]
ICD-10-PCS Topics
Removal of Thrombus and Emboli
Insertion of Endobronchial Coils
Hematopoietic Cell Transplant Donor
Fluorescence Vascular Angiography (FVA) (FVA)
Rapid Deployment Aortic Valve Replacement Replacement
Branch Endograft Repair of Common Iliac Aneurysm
Total Anomalous Pulmonary Venous Return
Administration of Andexanet Alfa
Injection for I.V. Infusion
Administration of VISTOGARD (uridine triacetate)
Mechanical Embolectomy with Stent Retriever Retrieve
Intracranial Aneurysm Procedure Using Flow Diverter Stent
Spinal Bracing and Distraction System
Interbody Spinal Fusion with Nano-Textured Surface
Therapeutic Artificial Rupture of Membranes
Application of Biologic Wound Matrix (MircoDERM)
Oxidized Zirconium on Polyethylene Bearing Surfaces
GEM Structure and Update Requests
Addenda and Key Updates
ICD-10-CM Diagnosis Topics
Antenatal Screening
Clostridium difficile
Congential Sacral Dimple
Exercise Counseling
Hepatic Encephalopathy
Lacunar Infarction
Pediatric Cryptorchidism
Post-operative Seroma
Soft Tissue Sarcoma
Spinal Stenosis
Temporomandibular Joint Disorders
Zika Virus Infection
ICD-10-CM Addendum
Agenda items are subject to change as priorities dictate.
Note: CMS and NCHS no longer provide paper copies of handouts
for the meeting. Electronic copies of all meeting materials will be
posted on the CMS and NCHS Web sites prior to the meeting at https://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm
Contact Persons for Additional Information: Donna Pickett,
Medical Systems Administrator, Classifications and Public Health
Data Standards Staff, NCHS, 3311 Toledo Road, Hyattsville, Maryland
20782, email dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady
Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500
Security Boulevard, Baltimore, Maryland 21244, email
marilu.hue@cms.hhs.gov, telephone 410-786-4510 (procedures).
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-03930 Filed 2-24-16; 8:45 am]
BILLING CODE 4163-18-P
